Shopping Cart
- Remove All
![TargetMol](https://newstatic.targetmol.com/error/oops.webp)
Your shopping cart is currently empty
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $78 | 35 days | |
5 mg | $297 | 35 days | |
10 mg | $460 | 35 days | |
25 mg | $575 | 35 days |
Description | Hesperin is a bioactive ingredient present in Japanese horseradish (wasabi). It has been shown to be an activator of Nrf2. |
In vitro | Hesperin is an active compound in wasabi. Whether Hesperin causes cytotoxicity of HUVECs is determined. To study the anti-coagulant and anti-inflammatory properties of Hesperin in HUVECs, in subsequent experiments we used Hesperin is used at concentrations of 0-1 μg/mL. More than 1 μg/mL of Hesperin markedly causes cytotoxicity and morphological alterations[2]. |
In vivo | Wild-type and Nrf2-null mice are fed the following diets for 12 weeks : 1) control diet, 2) high-fat diet (HFD), 3) HFD plus Hesperin (10 mg/kg/day ip), 4) HFD for 6 weeks followed by an iron-supplemented HFD for 6 weeks (HFD/Iron), 5) HFD/Iron plus Hesperin to determine whether Hesperin ameliorates hepatic steatosis and iron accumulation. Hesperin activates Nrf2 and causes phase II enzyme genes but this induction is absent in Nrf2-null mice, showing that Hesperin is a potential activator of the Nrf2/ARE-dependent detoxification pathway. The HFD enhanced hepatic triglycerides in both genotypes and Hesperin suppress increased hepatic triglycerides in wild-type mice but does not reduce these triglycerides in Nrf2-null mice[1]. |
Molecular Weight | 205.34 |
Formula | C8H15NOS2 |
Cas No. | 4430-35-7 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 50 mg/mL (243.50 mM) | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.